MORRIS HOUSE GROUP PRACTICE — All Prescriptions & Medications — Page 12
Practice Code: F85019 | LONDON, N17 6AA
Showing results 551-600 of 652
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Powder amino acid formula (0913131) | 16 | 137.6K | £13.3K | +50.1% ▲ |
| Benzalkonium chloride | 16 | 4,000 | £89 | +39.5% ▲ |
| Sodium fusidate | 16 | 285 | £46 | +189.7% ▲ |
| 16 | 160 | £13 | +337.3% ▲ | |
| 16 | 366 | £724 | -52.6% ▼ | |
| 16 | 160 | £430 | -66.5% ▼ | |
| Diltiazem hydrochloride | 15 | 510 | £198 | +223.9% ▲ |
| Simple | 15 | 3,000 | £22 | +30.7% ▲ |
| Modafinil | 15 | 872 | £144 | -28.1% ▼ |
| Co-trimoxazole(Trimethoprim/sulfamethoxazole) | 15 | 700 | £32 | -62.7% ▼ |
| Tube feed 1.3 kcal/ml peptide based (0914032) | 15 | 238.0K | £5.4K | +71.4% ▲ |
| Ketoprofen | 15 | 1,500 | £65 | -58.2% ▼ |
| Nicotinates | 15 | 960 | £41 | +358.6% ▲ |
| Nitrazepam | 14 | 1,256 | £66 | -73.1% ▼ |
| Rifaximin | 14 | 784 | £3.6K | -47.9% ▼ |
| Estradiol valerate | 14 | 392 | £34 | -28.3% ▼ |
| Ergocalciferol | 14 | 784 | £550 | -16.4% ▼ |
| 14 | 160 | £55 | +2.4% ▲ | |
| 14 | 209 | £510 | -10.8% ▼ | |
| 14 | 214 | £732 | -64.4% ▼ | |
| 14 | 212 | £134 | -30.8% ▼ | |
| 14 | 840 | £2.4K | +26.9% ▲ | |
| Alverine citrate | 13 | 1,260 | £48 | -68.6% ▼ |
| Prucalopride | 13 | 644 | £253 | -66.6% ▼ |
| Co-amilofruse (Amiloride hydrochloride/frusemide) | 13 | 728 | £86 | -62.6% ▼ |
| Co-tenidone (Atenolol/chlortalidone) | 13 | 728 | £78 | -37.7% ▼ |
| Opicapone | 13 | 752 | £1.5K | -32.1% ▼ |
| Powder amino acid formula (0913107) | 13 | 54.0K | £3.4K | -60.6% ▼ |
| RtS 3.3 - 4 kcal/ml energy with protein liquid (0913141) | 13 | 34.4K | £1.2K | -51.1% ▼ |
| Specialist food replacer pasta (0913261) | 13 | 6,000 | £105 | -11.7% ▼ |
| Prednisolone acetate | 13 | 130 | £45 | -28.7% ▼ |
| Loteprednol etabonate | 13 | 65 | £68 | +40.6% ▲ |
| Carbomer 974P | 13 | 230 | £98 | +60.5% ▲ |
| Hydrocortisone (Sodium succinate) | 13 | 600 | £222 | +669.6% ▲ |
| 13 | 135 | £33 | +121.1% ▲ | |
| 13 | 10.7K | £514 | -65.9% ▼ | |
| 13 | 24 | £113 | -68.1% ▼ | |
| 13 | 47 | £637 | +27.5% ▲ | |
| 13 | 390 | £736 | -12.5% ▼ | |
| 13 | 130 | £342 | -36.4% ▼ | |
| 13 | 630 | £1.4K | -8.1% ▼ | |
| 13 | 390 | £513 | -20.4% ▼ | |
| Lisinopril with diuretic | 12 | 672 | £227 | -41.5% ▼ |
| Lofepramine hydrochloride | 12 | 672 | £290 | -59.9% ▼ |
| Midazolam maleate | 12 | 24 | £1.1K | +148.7% ▲ |
| Trihexyphenidyl hydrochloride | 12 | 9,600 | £5.2K | -57.7% ▼ |
| Tetrabenazine | 12 | 1,344 | £1.4K | -24.3% ▼ |
| Acamprosate calcium | 12 | 2,016 | £224 | -65.5% ▼ |
| Betamethasone sodium phosphate | 12 | 1,202 | £156 | -2.4% ▼ |
| Potassium citrate | 12 | 184 | £60 | +41.4% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.